Back
Synopsys, Inc. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Sell
40
SNPS
Synopsys, Inc.
Last Price:
$465.83
Seasonality Move:
-0.51%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.58
Seasonality Move:
40.49%
Sell
40
Synopsys, Inc. (SNPS)
is a Sell
Is Synopsys, Inc. a Buy, Sell or Hold?
-
The current Synopsys, Inc. [SNPS] share price is $465.75. The Score for SNPS is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
SNPS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.60. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SNPS Stock Price Chart
What is Synopsys, Inc.'s stock price today?
-
The Synopsys, Inc. share price today is $465.75Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SNPS is experiencing slight buying pressure.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
SNPS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 8.11 | Buy |
| Relative Strength Index (14 RSI): | 67.16 | Buy |
| Chaikin Money Flow: | 636641 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (386.04 - 442.62) | Buy |
| Bollinger Bands (100): | (417.99 - 591.51) | Sell |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 6.94 | Buy |
| Relative Strength Index (14 RSI): | 75.92 | Buy |
| Chaikin Money Flow: | 249389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.15 - 56.87) | Buy |
| Bollinger Bands (100): | (20.01 - 44.73) | Buy |
SNPS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 447.25 | Buy |
| 20-day SMA: | 414.88 | Buy |
| 50-day SMA: | 438.16 | Buy |
| 200-day SMA: | 488.19 | Sell |
| 8-day EMA: | 448.79 | Buy |
| 20-day EMA: | 431.83 | Buy |
| 50-day EMA: | 444.64 | Buy |
| 200-day EMA: | 488.74 | Sell |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 60.55 | Buy |
| 20-day SMA: | 48.94 | Buy |
| 50-day SMA: | 42.23 | Buy |
| 200-day SMA: | 23.8 | Buy |
| 8-day EMA: | 60.08 | Buy |
| 20-day EMA: | 52.14 | Buy |
| 50-day EMA: | 43.49 | Buy |
| 200-day EMA: | 29.21 | Buy |
Synopsys, Inc. Earnings Growth & SNPS Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.30 per share, and an increase next year of $1.21 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Synopsys, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 24 | Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 24 | 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||